Author:
Vasyuk Yu. A.,Gendlin G. E.,Emelina E. I.,Shupenina E. Yu.,Ballyuzek M. F.,Barinova I. V.,Vitsenya M. V.,Davydkin I. L.,Dundua D. P.,Duplyakov D. V.,Zateishchikov D. A.,Zolotovskaya I. A.,Konradi A. O.,Lopatin Yu. M.,Moiseeva O. M.,Nedogoda S. V.,Nedoshivin A. O.,Nikitin I. G.,Poltavskaya M. G.,Potievskaya V. I.,Repin A. N.,Sumin А. N.,Zotova L. A.,Tumyan G. S.,Shlyakhto E. V.,Khatkov I. E.,Yakushin S. S.,Belenkov Yu. N.
Subject
Cardiology and Cardiovascular Medicine
Reference559 articles.
1. Eschenhagen T, Forse T, Ewer M, et al. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2011;13(1):1-10. doi:10.1093/eurjhf/hfq213.
2. Bedritsky SA, Larionova VB, Snegovoy AV. Clinical guidelines for cardiovascular toxicity induced by chemotherapy and targeted drugs. Moscow. 2014. р. 10. (In Russ.) http://www.oncology.ru/association/clinical-guidelines/2014/14.pdf.
3. Global WHO. Globocan 2020, all cancers [cited by 30 April, 2021]. Available from: gco.iarc.fr/today/data/factsheets/cancers/39-All-cancers-fact-sheet.pdf.
4. Padegimas A, Clasen S, Ky B. Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicity. Trends Cardiovasc Med. 2020;30:1:22-8. doi:10.1016/j.tcm2019.01.006.
5. Stiller CA. Global Burden Of Childhood Cancer: Growing, But Controllable. The Lancet Oncology. 2019;20(9):1184-5. doi:10.1016/s1470-2045(19)30163-9.